$2.23T
Total marketcap
$74.88B
Total volume
BTC 56.21%     ETH 9.01%
Dominance
us

Cytek Biosciences CTKB Stock

$4.07   5.440422%
Add to favorites
Market Cap
$525.61M
LOW - HIGH [24H]
$3.88 - $4.12
VOLUME [24H]
$1.41M
P/E Ratio
0
Earnings per share
-$0.58
ISIN
US23285D1090
Price   Prediction

Cytek Biosciences Price Chart

Sorry, that's all we've gotfor now...

Cytek Biosciences CTKB Financial and Trading Overview

Cytek Biosciences stock price 4.07 USD
Previous Close 3.77 USD
Open 3.82 USD
Bid 2.8 USD x 200
Ask 4.88 USD x 200
Day's Range 3.77 - 3.95 USD
52 Week Range 3.09 - 6.18 USD
Volume 1.87M USD
Avg. Volume 1.2M USD
Market Cap 498.49M USD
Beta (5Y Monthly) 1.186
PE Ratio (TTM) N/A
EPS (TTM) -0.58 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 5.69 USD

CTKB Valuation Measures

Enterprise Value 263.75M USD
Trailing P/E N/A
Forward P/E 20.315788
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.4415336
Price/Book (mrq) 1.5214821
Enterprise Value/Revenue 1.292
Enterprise Value/EBITDA -7.265

Trading Information

Cytek Biosciences Stock Price History

Beta (5Y Monthly) 1.186
52-Week Change 19.50%
S&P500 52-Week Change 22.66%
52 Week High 6.18 USD
52 Week Low 3.09 USD
50-Day Moving Average 4.22 USD
200-Day Moving Average 4.48 USD

CTKB Share Statistics

Avg. Volume (3 month) 1.2M USD
Avg. Daily Volume (10-Days) 3.44M USD
Shares Outstanding 129.14M
Float 96.54M
Short Ratio 7.05
% Held by Insiders 8.41%
% Held by Institutions 67.58%
Shares Short 7.3M
Short % of Float 7.16%
Short % of Shares Outstanding 5.65%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) March 31, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -36.24%
Operating Margin (ttm) -41.83%
Gross Margin 51.70%
EBITDA Margin -17.78%

Management Effectiveness

Return on Assets (ttm) -5.88%
Return on Equity (ttm) -20.92%

Income Statement

Revenue (ttm) 204.17M USD
Revenue Per Share (ttm) 1.6 USD
Quarterly Revenue Growth (yoy) 6.50%
Gross Profit (ttm) 105.56M USD
EBITDA -36303000 USD
Net Income Avi to Common (ttm) -74003000 USD
Diluted EPS (ttm) -0.58
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 262.22M USD
Total Cash Per Share (mrq) 2.03 USD
Total Debt (mrq) 27.48M USD
Total Debt/Equity (mrq) 8.39 USD
Current Ratio (mrq) 4.687
Book Value Per Share (mrq) 2.537

Cash Flow Statement

Operating Cash Flow (ttm) -7297000 USD
Levered Free Cash Flow (ttm) 6.41M USD

Profile of Cytek Biosciences

Country United States
State CA
City Fremont
Address 47215 Lakeview Blvd
ZIP 94538-6407
Phone 877 922 9835
Website https://cytekbio.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 678

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Q&A For Cytek Biosciences Stock

What is a current CTKB stock price?

Cytek Biosciences CTKB stock price today per share is 4.07 USD.

How to purchase Cytek Biosciences stock?

You can buy CTKB shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cytek Biosciences?

The stock symbol or ticker of Cytek Biosciences is CTKB.

Which industry does the Cytek Biosciences company belong to?

The Cytek Biosciences industry is Medical Devices.

How many shares does Cytek Biosciences have in circulation?

The max supply of Cytek Biosciences shares is 129.14M.

What is Cytek Biosciences Price to Earnings Ratio (PE Ratio)?

Cytek Biosciences PE Ratio is now.

What was Cytek Biosciences earnings per share over the trailing 12 months (TTM)?

Cytek Biosciences EPS is -0.58 USD over the trailing 12 months.

Which sector does the Cytek Biosciences company belong to?

The Cytek Biosciences sector is Healthcare.

Cytek Biosciences CTKB included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 25587.04 USD
-2.21
13.85B USD 25513.26 USD 25882.57 USD 13.85B USD
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 4123.39 USD
-2.34
4089.8 USD 4163.55 USD
us US Tech Health Care IXHC US 1184.66 USD
+0.75
1174.72 USD 1192.68 USD
us US Tech Global Select Market Com NQGS US 12546.99 USD
-2.24
12513.27 USD 12692.24 USD
us US Tech US 700 Small Cap Index NQUS700SC US 3090.39 USD
-0.26
3063.94 USD 3108.39 USD
Select currency